|Table of Contents|

Effect of radiolabeled GMBP1 peptide on cytotoxicity and induction of apoptosis of multiple drugs resistance cells in gastric cancer

Journal Of Modern Oncology[ISSN:1672-4992/CN:61-1415/R]

Issue:
2012 06
Page:
1106-1109
Research Field:
Publishing date:

Info

Title:
Effect of radiolabeled GMBP1 peptide on cytotoxicity and induction of apoptosis of multiple drugs resistance cells in gastric cancer
Author(s):
ZHANG Jing1LIANG Shuhui1KANG Jianqin1LIN Tao2WANG Biaoluo1DING Jie1
1.State Key Laboratory of Cancer Biology & Xijing Hospital of Digestive Disease, Fourth Military Medical University, Shaanxi Xi'an 710032, China; 2.Department of Digestive Diseases,Chinese PLA 451 Hospital, Shaanxi Xi'an 710054, China.
Keywords:
131I-GMBP1 apoptosis MTT peptide gastric cancer multiple drugs resistance
PACS:
R730.55;R735.2
DOI:
10.3969/j.issn.1672-4992.2012.06.04
Abstract:
Objective:To explore the effect of 131I-GMBP1 on cytotoxicity and induction of apoptosis of multiple drugs resistance (MDR) cells in gastric cancer. Methods: The Iodogen tube method was used to label GMBP1 with 131I. The cytotoxicity of 131I-GMBP1 on gastric cancer MDR cell SGC-7901/ACR was determined by MTT assay. Apoptosis of gastric cancer MDR cell SGC7901/ADR induced by 131I-GMBP1 was investigated by flow cytometry and Hoechst Staining Kit.Results:The radiolabeling efficiency and specific activity of 131I-GMBP1 was 93%-98% and 906.5GBq/mmol, respectively.131I-GMBP1 had remarkable cytotoxic effects on SGC-7901/ACR and could significantly inhibit the growth of SGC-7901/ACR. The IC50 of SGC-7901/ACR was 0.83μg/ml after 96 h exposure to 131I-GMBP1. After 60 h exposure to different concentration of 131I-GMBP1,131I and GMBP1, SGC-7901/ADR treated with 131I-GMBP1 showed pronounced cell apoptosis in a concentration-dependent manner. The highest cell apoptosis rate was 34.1%. The effect of 131I-GMBP1 on the cytotoxicity and induction of apoptosis of gastric cancer MDR cells was dependent on the concentration and time of 131I-GMBP1 exposure. Conclusion:131I-GMBP1 has strong effects on cytotoxicity and induction of apoptosis of gastric cancer MDR cells. These results provide an experimental basis for possible clinical application of 131I-GMBP1 alone or in combination with conventional antineoplastic agents in the treatment of MDR tumors.

References:

[1]JA Kim, EK Lee, SJ Park, et al. Novel anti-cancer role of naphthazarin in human gastric cancer cells[J]. Int J Oncol, 2012,40: 157-162.
[2]R Shi, W Li, X Zhang, et al. A novel indirubin derivative PHII-7 potentiates adriamycin cytotoxicity via inhibiting P-glycoprotein expression in human breast cancer MCF-7/ADR cells[J]. Eur J Pharmacol, 2011,669: 38-44.
[3]林涛.胃癌MDR细胞特异性结合及耐药逆转短肽的筛选[D].西安:第四军医大学,2006,30-62.
[4]PW Gold, FK Goodwin, T Wehr, et al. Growth-hormone and prolactin response to levodopa in affective illnessP[J]. Lancet, 1976,2: 1308-1309.
[5]CJ Reist, PK Garg, KL Alston, et al. Radioiodination of internalizing monoclonal antibodies using N-succinimidyl 5-iodo-3-pyridinecarboxylate[J]. Cancer Res, 1996,56: 4970-4977.
[6]J Castro, M Ribo, S Navarro, et al. A human ribonuclease induces apoptosis associated with p21WAF1/CIP1 induction and JNK inactivation[J]. BMC Cancer, 2011,11: 9.
[7]X Hui, Y Han, S Liang, et al. Specific targeting of the vasculature of gastric cancer by a new tumor-homing peptide CGNSNPKSC[J]. J Control Release, 2008,131: 86-93.
[8]I Dijkraaf, HJ Wester, Peptides, multimers and polymers[J]. Handb Exp Pharmacol, 2008, 61-92.
[9]L Tran, JW Baars, HJ Maessen, et al. A simple and safe method for 131I radiolabeling of rituximab for myeloablative high-dose radioimmunotherapy[J]. Cancer Biother Radiopharm, 2009,24:103-110.
[10]Z Liu, F Wang, X Chen.Integrin targeted delivery of radiotherapeutics[J]. Theranostics, 2011,1:201-210.
[11]AH Grossmann, WS Samowitz. Epidermal growth factor receptor pathway mutations and colorectal cancer therapy[J]. Arch Pathol Lab Med, 2011,135:1278-1282.
[12]许文静.胃癌多药耐药逆转短肽GMBP42的活性鉴定[J]. 现代肿瘤医学,2011,19(4):623-626.(编校:张志明)

Memo

Memo:
国家自然科学基金资助项目(编号:No. 30900674, No. 30973428, No. 30900704)
Last Update: 2012-06-11